Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-16 Sale |
2022-12-20 6:36 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Director |
10,000 | $61.87 | $618,657 | 422,984 (Direct) |
View |
| 2022-12-12 Sale |
2022-12-14 5:00 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Director |
3,944 | $64.8 | $255,571 | 453,319 (Direct) |
View |
| 2022-11-17 Sale |
2022-11-21 7:04 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
10,000 | $78.32 | $783,173 | 467,066 (Direct) |
View |
| 2022-11-09 Sale |
2022-11-10 4:30 pm |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,696 | $75.64 | $128,283 | 8,857 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 9:08 pm |
LIGAND PHARMACEUTICALS INC | LGND | Cochran Jennifer R. Former Director Director |
1,004 | $0 | $0 | 1,161 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 9:06 pm |
LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Former Director Director |
1,004 | $0 | $0 | 28,820 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 9:06 pm |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S Former Executive Officer |
11,944 | $0 | $0 | 23,825 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 9:06 pm |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W Former Executive Officer |
20,304 | $0 | $0 | 162,187 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 9:06 pm |
LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Former Director Director |
1,004 | $0 | $0 | 2,892 (Direct) |
View |
| 2022-09-16 Sale(A) |
2022-09-22 8:32 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
1,000 | $88.06 | $88,060 | 366,180 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-16 7:49 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
5,000 | $89.61 | $448,050 | 364,180 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-12-22 Option Award |
2022-12-27 6:34 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
25,967 | $0 | 25,967 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:31 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
6,623 | $0 | 6,623 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:31 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director |
3,050 | $0 | 3,050 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:30 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
6,623 | $0 | 6,623 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:28 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
4,484 | $0 | 4,484 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:26 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
4,484 | $0 | 4,484 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:26 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
2,081 | $0 | 2,081 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:26 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
6,620 | $0 | 6,620 (Direct) |
View |
| 2022-12-13 Option Award |
2022-12-15 6:17 pm |
N/A 2032-12-13 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
44,000 | $0 | 126,428 (Direct) |
View |
| 2022-12-13 Option Award |
2022-12-15 6:13 pm |
N/A 2032-12-13 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
31,000 | $0 | 38,670 (Direct) |
View |
| 2022-12-12 Exercise |
2022-12-14 5:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Director |
20,000 | $12.78 | 453,319 (Direct) |
View |
| 2022-12-12 Exercise |
2022-12-14 5:00 pm |
N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Director |
20,000 | $0 | 453,319 (Direct) |
View |
| 2022-12-05 Option Award |
2022-12-06 8:25 pm |
N/A 2032-12-05 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
132,000 | $0 | 132,000 (Direct) |
View |
| 2022-11-30 Tax Withholding |
2022-12-01 9:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
3,593 | $72.9 | 82,428 (Direct) |
View |
| 2022-11-30 Tax Withholding |
2022-12-01 9:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
9,803 | $72.9 | 416,928 (Direct) |
View |
| 2022-11-30 Tax Withholding |
2022-12-01 9:41 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,187 | $72.9 | 7,670 (Direct) |
View |
| 2022-11-30 Tax Withholding |
2022-12-01 9:39 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks |
1,073 | $72.9 | 10,940 (Direct) |
View |
| 2022-11-18 Exercise |
2022-11-21 7:04 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
10,000 | $12.78 | 467,066 (Direct) |
View |
| 2022-11-18 Exercise |
2022-11-21 7:04 pm |
N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
10,000 | $0 | 467,066 (Direct) |
View |
Ownership |
2022-11-07 8:26 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
0 | $0 | 62,802 (Direct) |
View |
Ownership |
2022-11-07 8:23 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks |
0 | $0 | 84,957 (Direct) |
View |
| 2022-11-01 Other |
2022-11-03 9:12 pm |
N/A N/A |
OmniAb Operations Inc. | LIGAND PHARMACEUTICALS INC 10% Owner |
16,859,308 | $0 | 16,859,308 (Direct) |
View | |
| 2022-11-01 Option Award |
2022-11-03 9:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
27,714 | $0 | 86,021 (Direct) |
View |
| 2022-11-01 Option Award |
2022-11-03 9:05 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
45,922 | $0 | 424,731 (Direct) |
View |
Ownership |
2022-09-30 7:59 pm |
N/A N/A |
OmniAb Inc. | LIGAND PHARMACEUTICALS INC 10% Owner |
0 | $0 | 1,000 (Direct) |
View | |
| 2022-06-30 Other |
2022-07-06 8:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
164 | $75.84 | 52,696 (Direct) |
View |
| 2022-06-30 Other |
2022-07-06 8:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
164 | $75.84 | 369,344 (Direct) |
View |
| 2022-06-29 Option Award |
2022-06-30 6:32 pm |
N/A 2032-06-29 |
LIGAND PHARMACEUTICALS INC | LGND | Haas Jason Director |
7,657 | $0 | 7,657 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 5:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
5,375 | $0 | 35,769 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 5:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
9,137 | $0 | 182,491 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 5:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
20,423 | $0 | 369,016 (Direct) |
View |